Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evogene (EVGN) Inventory (2021 - 2025)

Historic Inventory for Evogene (EVGN) over the last 5 years, with Q3 2025 value amounting to $2.1 million.

  • Evogene's Inventory rose 4498.63% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 4498.63%. This contributed to the annual value of $1.8 million for FY2024, which is 229342.11% up from last year.
  • As of Q3 2025, Evogene's Inventory stood at $2.1 million, which was up 4498.63% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, Evogene's Inventory ranged from a high of $2.2 million in Q1 2025 and a low of $76000.0 during Q4 2023
  • In the last 5 years, Evogene's Inventory had a median value of $578500.0 in 2022 and averaged $824312.5.
  • In the last 5 years, Evogene's Inventory tumbled by 8657.24% in 2023 and then soared by 229342.11% in 2024.
  • Evogene's Inventory (Quarter) stood at $92000.0 in 2021, then skyrocketed by 515.22% to $566000.0 in 2022, then plummeted by 86.57% to $76000.0 in 2023, then skyrocketed by 2293.42% to $1.8 million in 2024, then increased by 16.05% to $2.1 million in 2025.
  • Its Inventory was $2.1 million in Q3 2025, compared to $2.0 million in Q2 2025 and $2.2 million in Q1 2025.